What is PBM's P/E ratio?

Psyence Biomedical LTD. Common Shares (PBM) currently trades at a P/E ratio of 45.30.

Psyence Biomedical LTD. Common Shares reports a Return on Equity (ROE) of -212.63%.

What is PBM's dividend yield?

Psyence Biomedical LTD. Common Shares offers a dividend yield of 0.00%.

What is PBM's Quality Score?

Our AI rates PBM's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PBM?

Our AI Timing Score for PBM is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PBM belong to?

Psyence Biomedical LTD. Common Shares is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Psyence Biomedical LTD. Common Shares (PBM) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2025-09-30)

PBM AI Analysis Summary

Our AI summary for PBM: Psyence Biomedical LTD. Common Shares (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 45.30, ROE of -212.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PBM

Psyence Biomedical LTD. Common Shares

US:NASDAQ STOCK Healthcare >> Biotechnology News 87

USD 3.29

0.10 (3.13%) Day Change

Watchlist Portfolio Compare Chart

45.30

P/E

0.08

D/E

-212.6%

ROE

-197.0%

ROA

0.00%

Div Yield

-0.04

PEG

PSYENCE BIOMEDICAL LTD. COMMON SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.29 Price 0.10 (3.13%) Day Change	NEWS SCORE: 87

PBM, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.29
PBV / Sector	1.08 / 44,105.10 GREAT
Earning Per Share	-6.48

PE / Sector	45.30 / 19.37
PEG or PE/Growth / Sector	-0.04 / 1.06
Average 1M Daily Value	0.25 M GREAT
Average 1W Daily Value	0.41 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-196.98 / 185,260.64
ROA Average (%) / Sector	-947.65 / 36,684.64
ROA Change Average (%) / Sector	-36,545.06 / 422,221.42
ROE (%) / Sector	-212.63 / 243,761.81
ROE Average (%) / Sector	46.20 / 48,758.38 GREAT
ROE Change Average (%) / Sector	3,521.04 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 08:00:28
Symbol	PBM
Name	PSYENCE BIOMEDICAL LTD. COMMON SHARES
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	3.81 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	12.82 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 121 Richmond Street West, Toronto, ON, Canada, M5H 2K1

Phone: 416-477-1708

Website: https://psyencebiomed.com

Sector: Healthcare >> Biotechnology

Description: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.